# Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

> **NCT07155525** · PHASE3 · RECRUITING · sponsor: **Minia University** · enrollment: 194 (estimated)

## Conditions studied

- Pancreatic Cancer
- Periampullary Cancer
- Duodenal Cancer
- Cholangiocarcinoma
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Head Mass
- Bile Duct Cancer

## Interventions

- **DRUG:** Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2)
- **PROCEDURE:** Standard(duct-to-mucosa) Pancreaticojejunostomy

## Key facts

- **NCT ID:** NCT07155525
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2028-09-15
- **Final completion:** 2028-11-15
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155525, "Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07155525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*